WP
CLDI.WS

Woodline Partners’s Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 CLDI.WS Stock Holding History

Woodline Partners’s Portfolio CLDI.WS Stock Details CLDI.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-437,431
Closed -$39K – 850
2022
Q2 		$39K Sell
437,431
-552,569
-56% -$49.3K ﹤0.01% 644
2022
Q1 		$356K Hold
990,000
– – 0.01% 526
2021
Q4 		$495K Buy
+990,000
New +$495K 0.01% 550